speb/financial-data huggingface dataset:
CLOV balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 233156000.00
CLOV balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 233156000.00
CLOV balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 23484000.00
CLOV balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 23484000.00
CLOV income_statement (annual, 2025-12-31) — Total Operating Income As Reported: -85529000.00
CLOV income_statement (quarterly, 2025-12-31) — Total Operating Income As Reported: -49319000.00
CLOV income_statement (annual, 2025-12-31) — Total Unusual Items: -20000.00
CLOV income_statement (quarterly, 2025-12-31) — Total Unusual Items: -1000.00
CLOV income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: -20000.00
CLOV income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: -1000.00
CLOV balance_sheet (annual, 2025-12-31) — Treasury Shares Number: 33412273.00
CLOV balance_sheet (quarterly, 2025-12-31) — Treasury Shares Number: 33412273.00
CLOV balance_sheet (annual, 2025-12-31) — Treasury Stock: 86187000.00
CLOV balance_sheet (quarterly, 2025-12-31) — Treasury Stock: 86187000.00
CLOV balance_sheet (annual, 2025-12-31) — Working Capital: 99032000.00
CLOV balance_sheet (quarterly, 2025-12-31) — Working Capital: 99032000.00
CLOV income_statement (quarterly, 2026-03-31) — +Operating Expense: 132207000.00
CLOV income_statement (quarterly, 2026-03-31) — +Total Revenue: 749189000.00
CLOV balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 39170000.00
CLOV balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 2695144000.00
CLOV balance_sheet (quarterly, 2026-03-31) — Available For Sale Securities: 202240000.00
CLOV income_statement (quarterly, 2026-03-31) — Basic Average Shares: 522184385.00
CLOV income_statement (quarterly, 2026-03-31) — Basic EPS: 0.05
CLOV cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 78301000.00
CLOV cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -854000.00
CLOV balance_sheet (quarterly, 2026-03-31) — Capital Stock: 52000.00
CLOV balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 173265000.00
CLOV balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 203543000.00
CLOV cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: -7863000.00
CLOV cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: -5068000.00
CLOV cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: 107895000.00
CLOV cash_flow (quarterly, 2026-03-31) — Change In Account Payable: 2959000.00
CLOV cash_flow (quarterly, 2026-03-31) — Change In Accrued Expense: 15192000.00
CLOV cash_flow (quarterly, 2026-03-31) — Change In Other Current Assets: -13730000.00
CLOV cash_flow (quarterly, 2026-03-31) — Change In Other Current Liabilities: 677000.00
CLOV cash_flow (quarterly, 2026-03-31) — Change In Other Working Capital: 107167000.00
CLOV cash_flow (quarterly, 2026-03-31) — Change In Payable: 2959000.00
CLOV cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: 18151000.00
CLOV cash_flow (quarterly, 2026-03-31) — Change In Prepaid Assets: -214000.00
CLOV cash_flow (quarterly, 2026-03-31) — Change In Receivables: -43948000.00
CLOV cash_flow (quarterly, 2026-03-31) — Change In Working Capital: 68103000.00
CLOV cash_flow (quarterly, 2026-03-31) — Changes In Cash: 94964000.00
CLOV balance_sheet (quarterly, 2026-03-31) — Common Stock: 52000.00
CLOV balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 339426000.00
CLOV cash_flow (quarterly, 2026-03-31) — Common Stock Issuance: 30000.00
CLOV cash_flow (quarterly, 2026-03-31) — Common Stock Payments: -7893000.00
CLOV income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 589648000.00
CLOV balance_sheet (quarterly, 2026-03-31) — Current Accrued Expenses: 31230000.00
CLOV balance_sheet (quarterly, 2026-03-31) — Current Assets: 448021000.00
CLOV balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 336583000.00
CLOV cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 515000.00
CLOV income_statement (quarterly, 2026-03-31) — Depreciation Amortization Depletion Income Statement: 515000.00
CLOV cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 515000.00
CLOV income_statement (quarterly, 2026-03-31) — Depreciation And Amortization In Income Statement: 515000.00
CLOV income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 532501448.00
CLOV income_statement (quarterly, 2026-03-31) — Diluted EPS: 0.05
CLOV income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 27334000.00
CLOV income_statement (quarterly, 2026-03-31) — EBIT: 27334000.00
CLOV income_statement (quarterly, 2026-03-31) — EBITDA: 27849000.00
CLOV cash_flow (quarterly, 2026-03-31) — End Cash Position: 173265000.00
CLOV cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: -7863000.00
CLOV cash_flow (quarterly, 2026-03-31) — Free Cash Flow: 107041000.00
CLOV cash_flow (quarterly, 2026-03-31) — Gain Loss On Investment Securities: -28000.00
CLOV balance_sheet (quarterly, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: -672000.00
CLOV income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 131692000.00
CLOV balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 2990000.00
CLOV balance_sheet (quarterly, 2026-03-31) — Gross PPE: 6904000.00
CLOV income_statement (quarterly, 2026-03-31) — Gross Profit: 159541000.00
CLOV balance_sheet (quarterly, 2026-03-31) — Held To Maturity Securities: 12444000.00
CLOV balance_sheet (quarterly, 2026-03-31) — Invested Capital: 339426000.00
CLOV cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: -5068000.00
CLOV balance_sheet (quarterly, 2026-03-31) — Investmentin Financial Assets: 214684000.00
CLOV balance_sheet (quarterly, 2026-03-31) — Investments And Advances: 214684000.00
CLOV cash_flow (quarterly, 2026-03-31) — Issuance Of Capital Stock: 30000.00
CLOV cash_flow (quarterly, 2026-03-31) — Net Common Stock Issuance: -7863000.00
CLOV income_statement (quarterly, 2026-03-31) — Net Income: 27334000.00
CLOV income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 27334000.00
CLOV income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 27334000.00
CLOV income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 27334000.00
CLOV income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 27334000.00
CLOV cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: 27334000.00
CLOV income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 27334000.00
CLOV cash_flow (quarterly, 2026-03-31) — Net Investment Purchase And Sale: -4214000.00
CLOV balance_sheet (quarterly, 2026-03-31) — Net PPE: 6904000.00
CLOV cash_flow (quarterly, 2026-03-31) — Net PPE Purchase And Sale: -854000.00
CLOV balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 336436000.00
CLOV income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 27849000.00
CLOV income_statement (quarterly, 2026-03-31) — Normalized Income: 27334000.00
CLOV cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: 107895000.00
CLOV cash_flow (quarterly, 2026-03-31) — Operating Gains Losses: -28000.00
CLOV income_statement (quarterly, 2026-03-31) — Operating Income: 27334000.00
CLOV income_statement (quarterly, 2026-03-31) — Operating Revenue: 744189000.00
CLOV balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 525271434.00
CLOV balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 23366000.00
CLOV balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 5766000.00
CLOV balance_sheet (quarterly, 2026-03-31) — Other Equity Adjustments: -672000.00
CLOV income_statement (quarterly, 2026-03-31) — Other Gand A: 74629000.00
CLOV cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: -300000.00
CLOV balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 25129000.00
CLOV balance_sheet (quarterly, 2026-03-31) — Other Non Current Liabilities: 21719000.00
CLOV balance_sheet (quarterly, 2026-03-31) — Other Payable: 260417000.00
CLOV balance_sheet (quarterly, 2026-03-31) — Other Properties: 6904000.00
CLOV balance_sheet (quarterly, 2026-03-31) — Other Receivables: 202689000.00
CLOV balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 30278000.00
CLOV balance_sheet (quarterly, 2026-03-31) — Payables: 299587000.00
CLOV balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 330817000.00
CLOV balance_sheet (quarterly, 2026-03-31) — Prepaid Assets: 18423000.00
CLOV income_statement (quarterly, 2026-03-31) — Pretax Income: 27334000.00
CLOV cash_flow (quarterly, 2026-03-31) — Purchase Of Investment: -40915000.00
CLOV cash_flow (quarterly, 2026-03-31) — Purchase Of PPE: -854000.00
CLOV balance_sheet (quarterly, 2026-03-31) — Receivables: 202689000.00
CLOV income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 589648000.00
CLOV income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 515000.00
CLOV cash_flow (quarterly, 2026-03-31) — Repurchase Of Capital Stock: -7893000.00
CLOV balance_sheet (quarterly, 2026-03-31) — Retained Earnings: -2261018000.00
CLOV income_statement (quarterly, 2026-03-31) — Salaries And Wages: 57063000.00
CLOV cash_flow (quarterly, 2026-03-31) — Sale Of Investment: 36701000.00
CLOV income_statement (quarterly, 2026-03-31) — Selling General And Administration: 131692000.00
CLOV balance_sheet (quarterly, 2026-03-31) — Share Issued: 560249104.00
CLOV cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 12271000.00
CLOV balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 339426000.00
CLOV balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 336436000.00
CLOV income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
CLOV income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.00
CLOV balance_sheet (quarterly, 2026-03-31) — Total Assets: 697728000.00
CLOV balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 339426000.00
CLOV balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 339426000.00
CLOV income_statement (quarterly, 2026-03-31) — Total Expenses: 721855000.00
CLOV balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 358302000.00
CLOV balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 249707000.00
CLOV balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 21719000.00
CLOV income_statement (quarterly, 2026-03-31) — Total Operating Income As Reported: 27334000.00
CLOV balance_sheet (quarterly, 2026-03-31) — Treasury Shares Number: 34977670.00
CLOV balance_sheet (quarterly, 2026-03-31) — Treasury Stock: 94080000.00
CLOV balance_sheet (quarterly, 2026-03-31) — Working Capital: 111438000.00
CLPR cash_flow (annual, 2021-12-31) — Amortization Cash Flow: -104000.00
CLPR cash_flow (annual, 2021-12-31) — Amortization Of Intangibles: -104000.00
CLPR balance_sheet (annual, 2021-12-31) — Capital Lease Obligations: 53000.00
CLPR cash_flow (annual, 2021-12-31) — Common Stock Payments: 0.00
CLPR balance_sheet (annual, 2021-12-31) — Long Term Capital Lease Obligation: 53000.00
CLPR cash_flow (annual, 2021-12-31) — Net Business Purchase And Sale: -2015000.00
CLPR cash_flow (annual, 2021-12-31) — Net Common Stock Issuance: 0.00
CLPR cash_flow (annual, 2021-12-31) — Net Investment Purchase And Sale: 0.00
CLPR cash_flow (annual, 2021-12-31) — Net Other Financing Charges: -7260000.00
CLPR cash_flow (annual, 2021-12-31) — Net Other Investing Changes: 150000.00
CLPR cash_flow (annual, 2021-12-31) — Operating Gains Losses: 3034000.00
CLPR income_statement (annual, 2021-12-31) — Other Non Operating Income Expenses: -60000.00
CLPR income_statement (annual, 2021-12-31) — Other Special Charges: 5625000.00
CLPR balance_sheet (annual, 2021-12-31) — Prepaid Assets: 15641000.00
CLPR cash_flow (annual, 2021-12-31) — Purchase Of Business: -2015000.00
CLPR balance_sheet (annual, 2021-12-31) — Receivables Adjustments Allowances: -7905000.00
CLPR cash_flow (annual, 2021-12-31) — Repurchase Of Capital Stock: 0.00
CLPR income_statement (annual, 2022-12-31) — +Operating Expense: 39737000.00
CLPR income_statement (annual, 2022-12-31) — +Total Revenue: 129746000.00
CLPR balance_sheet (annual, 2022-12-31) — Accounts Receivable: 5005000.00
CLPR balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 88829000.00
CLPR balance_sheet (annual, 2022-12-31) — Allowance For Doubtful Accounts Receivable: -321000.00
CLPR cash_flow (annual, 2022-12-31) — Amortization Cash Flow: -35000.00
CLPR cash_flow (annual, 2022-12-31) — Amortization Of Intangibles: -35000.00
CLPR cash_flow (annual, 2022-12-31) — Asset Impairment Charge: -236000.00
CLPR income_statement (annual, 2022-12-31) — Basic Average Shares: 16063000.00
CLPR income_statement (annual, 2022-12-31) — Basic EPS: -0.36
CLPR cash_flow (annual, 2022-12-31) — Beginning Cash Position: 52224000.00
CLPR balance_sheet (annual, 2022-12-31) — Capital Lease Obligations: 18000.00
CLPR balance_sheet (annual, 2022-12-31) — Capital Stock: 160000.00
CLPR balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 18152000.00
CLPR balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 18152000.00
CLPR cash_flow (annual, 2022-12-31) — Cash Dividends Paid: -17073000.00
CLPR cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: 9779000.00
CLPR cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: -51476000.00
CLPR cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: 20139000.00
CLPR cash_flow (annual, 2022-12-31) — Change In Other Current Liabilities: -22000.00
CLPR cash_flow (annual, 2022-12-31) — Change In Payables And Accrued Expense: 1222000.00
CLPR cash_flow (annual, 2022-12-31) — Change In Prepaid Assets: 616000.00
CLPR cash_flow (annual, 2022-12-31) — Change In Receivables: -310000.00
CLPR cash_flow (annual, 2022-12-31) — Change In Working Capital: 1506000.00
CLPR cash_flow (annual, 2022-12-31) — Changes In Cash: -21558000.00
CLPR balance_sheet (annual, 2022-12-31) — Common Stock: 160000.00
CLPR cash_flow (annual, 2022-12-31) — Common Stock Dividend Paid: -17073000.00
CLPR balance_sheet (annual, 2022-12-31) — Common Stock Equity: 14094000.00
CLPR income_statement (annual, 2022-12-31) — Cost Of Revenue: 61867000.00
CLPR balance_sheet (annual, 2022-12-31) — Current Assets: 49325000.00
CLPR balance_sheet (annual, 2022-12-31) — Current Liabilities: 17094000.00
CLPR cash_flow (annual, 2022-12-31) — Depreciation: 26779000.00
CLPR cash_flow (annual, 2022-12-31) — Depreciation Amortization Depletion: 26744000.00
CLPR income_statement (annual, 2022-12-31) — Depreciation Amortization Depletion Income Statement: 26985000.00
CLPR cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 26744000.00
CLPR income_statement (annual, 2022-12-31) — Depreciation And Amortization In Income Statement: 26985000.00
CLPR income_statement (annual, 2022-12-31) — Diluted Average Shares: 16063000.00
CLPR income_statement (annual, 2022-12-31) — Diluted EPS: -0.36
CLPR income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: -5732000.00
CLPR income_statement (annual, 2022-12-31) — EBIT: 27636000.00
CLPR income_statement (annual, 2022-12-31) — EBITDA: 54621000.00
CLPR cash_flow (annual, 2022-12-31) — End Cash Position: 30666000.00
CLPR cash_flow (annual, 2022-12-31) — Financing Cash Flow: 9779000.00
CLPR cash_flow (annual, 2022-12-31) — Free Cash Flow: 20139000.00
CLPR income_statement (annual, 2022-12-31) — General And Administrative Expense: 12752000.00
CLPR balance_sheet (annual, 2022-12-31) — Goodwill And Other Intangible Assets: 6276000.00
CLPR balance_sheet (annual, 2022-12-31) — Gross Accounts Receivable: 5326000.00
CLPR income_statement (annual, 2022-12-31) — Gross Profit: 67879000.00
CLPR income_statement (annual, 2022-12-31) — Interest Expense: 40207000.00
CLPR income_statement (annual, 2022-12-31) — Interest Expense Non Operating: 40207000.00
CLPR cash_flow (annual, 2022-12-31) — Interest Paid Supplemental Data: 38989000.00
CLPR balance_sheet (annual, 2022-12-31) — Invested Capital: 1175682000.00
CLPR cash_flow (annual, 2022-12-31) — Investing Cash Flow: -51476000.00
CLPR balance_sheet (annual, 2022-12-31) — Investment Properties: 1171109000.00
CLPR cash_flow (annual, 2022-12-31) — Issuance Of Debt: 29378000.00
CLPR balance_sheet (annual, 2022-12-31) — Long Term Capital Lease Obligation: 18000.00
CLPR balance_sheet (annual, 2022-12-31) — Long Term Debt: 1161588000.00
CLPR balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 1161606000.00
CLPR cash_flow (annual, 2022-12-31) — Long Term Debt Issuance: 29378000.00
CLPR cash_flow (annual, 2022-12-31) — Long Term Debt Payments: -2191000.00
CLPR balance_sheet (annual, 2022-12-31) — Minority Interest: 23085000.00
CLPR income_statement (annual, 2022-12-31) — Minority Interests: 7807000.00
CLPR cash_flow (annual, 2022-12-31) — Net Business Purchase And Sale: 2015000.00
CLPR balance_sheet (annual, 2022-12-31) — Net Debt: 1143436000.00
CLPR income_statement (annual, 2022-12-31) — Net Income: -4764000.00
CLPR income_statement (annual, 2022-12-31) — Net Income Common Stockholders: -5732000.00
CLPR income_statement (annual, 2022-12-31) — Net Income Continuous Operations: -12571000.00
CLPR income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: -4764000.00
CLPR income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: -4764000.00
CLPR cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: -12571000.00
CLPR income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: -12571000.00
CLPR income_statement (annual, 2022-12-31) — Net Interest Income: -40207000.00
CLPR cash_flow (annual, 2022-12-31) — Net Investment Properties Purchase And Sale: -53491000.00
CLPR cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: 27187000.00
CLPR cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: 27187000.00
CLPR income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: -40207000.00
CLPR cash_flow (annual, 2022-12-31) — Net Other Financing Charges: -335000.00
CLPR balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 7818000.00
CLPR balance_sheet (annual, 2022-12-31) — Non Current Deferred Assets: 2921000.00
CLPR income_statement (annual, 2022-12-31) — Normalized EBITDA: 55127000.00
CLPR income_statement (annual, 2022-12-31) — Normalized Income: -4258000.00
CLPR cash_flow (annual, 2022-12-31) — Operating Cash Flow: 20139000.00
CLPR income_statement (annual, 2022-12-31) — Operating Income: 28142000.00
CLPR income_statement (annual, 2022-12-31) — Operating Revenue: 129746000.00
CLPR balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 16063228.00
CLPR balance_sheet (annual, 2022-12-31) — Other Current Assets: 13654000.00
CLPR income_statement (annual, 2022-12-31) — Other Gand A: 12752000.00
CLPR income_statement (annual, 2022-12-31) — Other Income Expense: -506000.00
CLPR balance_sheet (annual, 2022-12-31) — Other Intangible Assets: 6276000.00
CLPR cash_flow (annual, 2022-12-31) — Other Non Cash Items: 1776000.00
CLPR balance_sheet (annual, 2022-12-31) — Other Non Current Liabilities: 13752000.00
CLPR income_statement (annual, 2022-12-31) — Otherunder Preferred Stock Dividend: 968000.00
CLPR balance_sheet (annual, 2022-12-31) — Payables And Accrued Expenses: 17094000.00
CLPR balance_sheet (annual, 2022-12-31) — Preferred Stock: 0.00
CLPR income_statement (annual, 2022-12-31) — Pretax Income: -12571000.00
CLPR cash_flow (annual, 2022-12-31) — Purchase Of Investment Properties: -53491000.00
CLPR balance_sheet (annual, 2022-12-31) — Receivables: 5005000.00
CLPR income_statement (annual, 2022-12-31) — Reconciled Cost Of Revenue: 62108000.00
CLPR income_statement (annual, 2022-12-31) — Reconciled Depreciation: 26744000.00
CLPR cash_flow (annual, 2022-12-31) — Repayment Of Debt: -2191000.00
CLPR balance_sheet (annual, 2022-12-31) — Restricted Cash: 12514000.00
CLPR income_statement (annual, 2022-12-31) — Restructuring And Mergern Acquisition: 506000.00
CLPR balance_sheet (annual, 2022-12-31) — Retained Earnings: -74895000.00
CLPR cash_flow (annual, 2022-12-31) — Sale Of Business: 2015000.00
CLPR income_statement (annual, 2022-12-31) — Selling General And Administration: 12752000.00
CLPR balance_sheet (annual, 2022-12-31) — Share Issued: 16063228.00
CLPR income_statement (annual, 2022-12-31) — Special Income Charges: -506000.00
CLPR cash_flow (annual, 2022-12-31) — Stock Based Compensation: 2920000.00
CLPR balance_sheet (annual, 2022-12-31) — Stockholders Equity: 14094000.00
CLPR balance_sheet (annual, 2022-12-31) — Tangible Book Value: 7818000.00
CLPR income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: 0.00
CLPR income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.00
CLPR balance_sheet (annual, 2022-12-31) — Total Assets: 1229631000.00
CLPR balance_sheet (annual, 2022-12-31) — Total Capitalization: 1175682000.00
CLPR balance_sheet (annual, 2022-12-31) — Total Debt: 1161606000.00
CLPR balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 37179000.00
CLPR income_statement (annual, 2022-12-31) — Total Expenses: 101604000.00
CLPR balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 1192452000.00
CLPR balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 1180306000.00
CLPR balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 1175358000.00
CLPR income_statement (annual, 2022-12-31) — Total Operating Income As Reported: 27636000.00
CLPR income_statement (annual, 2022-12-31) — Total Unusual Items: -506000.00
CLPR income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: -506000.00
CLPR balance_sheet (annual, 2022-12-31) — Working Capital: 32231000.00
CLPR income_statement (annual, 2023-12-31) — +Operating Expense: 42108000.00
CLPR income_statement (annual, 2023-12-31) — +Total Revenue: 138205000.00
CLPR balance_sheet (annual, 2023-12-31) — Accounts Receivable: 5181000.00
CLPR balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 89483000.00
CLPR balance_sheet (annual, 2023-12-31) — Allowance For Doubtful Accounts Receivable: -234000.00
CLPR cash_flow (annual, 2023-12-31) — Amortization Cash Flow: -18000.00
CLPR cash_flow (annual, 2023-12-31) — Amortization Of Intangibles: -18000.00
CLPR cash_flow (annual, 2023-12-31) — Asset Impairment Charge: -87000.00
CLPR income_statement (annual, 2023-12-31) — Basic Average Shares: 16063000.00
CLPR income_statement (annual, 2023-12-31) — Basic EPS: -0.45
CLPR cash_flow (annual, 2023-12-31) — Beginning Cash Position: 30666000.00
CLPR balance_sheet (annual, 2023-12-31) — Capital Lease Obligations: 0.00
CLPR balance_sheet (annual, 2023-12-31) — Capital Stock: 160000.00
CLPR balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 22163000.00
CLPR balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 22163000.00
CLPR cash_flow (annual, 2023-12-31) — Cash Dividends Paid: -17394000.00
CLPR cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: 20731000.00
CLPR cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: -41357000.00
CLPR cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Operating Activities: 26185000.00
CLPR cash_flow (annual, 2023-12-31) — Change In Other Current Liabilities: 900000.00
CLPR cash_flow (annual, 2023-12-31) — Change In Payables And Accrued Expense: -707000.00
CLPR cash_flow (annual, 2023-12-31) — Change In Prepaid Assets: 3526000.00
CLPR cash_flow (annual, 2023-12-31) — Change In Receivables: -86000.00
CLPR cash_flow (annual, 2023-12-31) — Change In Working Capital: 3633000.00
CLPR cash_flow (annual, 2023-12-31) — Changes In Cash: 5559000.00
CLPR balance_sheet (annual, 2023-12-31) — Common Stock: 160000.00
CLPR cash_flow (annual, 2023-12-31) — Common Stock Dividend Paid: -17394000.00
CLPR balance_sheet (annual, 2023-12-31) — Common Stock Equity: 2744000.00
CLPR income_statement (annual, 2023-12-31) — Cost Of Revenue: 62570000.00
CLPR balance_sheet (annual, 2023-12-31) — Current Assets: 52260000.00
CLPR balance_sheet (annual, 2023-12-31) — Current Liabilities: 20994000.00
CLPR cash_flow (annual, 2023-12-31) — Depreciation: 28825000.00
CLPR cash_flow (annual, 2023-12-31) — Depreciation Amortization Depletion: 28807000.00
CLPR income_statement (annual, 2023-12-31) — Depreciation Amortization Depletion Income Statement: 28939000.00
CLPR cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 28807000.00
CLPR income_statement (annual, 2023-12-31) — Depreciation And Amortization In Income Statement: 28939000.00
CLPR income_statement (annual, 2023-12-31) — Diluted Average Shares: 16063000.00
CLPR income_statement (annual, 2023-12-31) — Diluted EPS: -0.45
CLPR income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: -7189000.00
CLPR income_statement (annual, 2023-12-31) — EBIT: 29302000.00
CLPR income_statement (annual, 2023-12-31) — EBITDA: 58241000.00
CLPR cash_flow (annual, 2023-12-31) — End Cash Position: 36225000.00
CLPR cash_flow (annual, 2023-12-31) — Financing Cash Flow: 20731000.00
CLPR cash_flow (annual, 2023-12-31) — Free Cash Flow: 26185000.00
CLPR income_statement (annual, 2023-12-31) — General And Administrative Expense: 13169000.00
CLPR balance_sheet (annual, 2023-12-31) — Goodwill And Other Intangible Assets: 5779000.00
CLPR balance_sheet (annual, 2023-12-31) — Gross Accounts Receivable: 5415000.00
CLPR income_statement (annual, 2023-12-31) — Gross Profit: 75635000.00
CLPR income_statement (annual, 2023-12-31) — Interest Expense: 44867000.00
CLPR income_statement (annual, 2023-12-31) — Interest Expense Non Operating: 44867000.00
CLPR cash_flow (annual, 2023-12-31) — Interest Paid Supplemental Data: 45323000.00
CLPR balance_sheet (annual, 2023-12-31) — Invested Capital: 1208368000.00
CLPR cash_flow (annual, 2023-12-31) — Investing Cash Flow: -41357000.00
CLPR balance_sheet (annual, 2023-12-31) — Investment Properties: 1188584000.00
CLPR cash_flow (annual, 2023-12-31) — Issuance Of Debt: 132519000.00
CLPR balance_sheet (annual, 2023-12-31) — Long Term Capital Lease Obligation: 0.00
CLPR balance_sheet (annual, 2023-12-31) — Long Term Debt: 1205624000.00
CLPR balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 1205624000.00
CLPR cash_flow (annual, 2023-12-31) — Long Term Debt Issuance: 132519000.00
CLPR cash_flow (annual, 2023-12-31) — Long Term Debt Payments: -84728000.00
CLPR balance_sheet (annual, 2023-12-31) — Minority Interest: 4491000.00
CLPR income_statement (annual, 2023-12-31) — Minority Interests: 9665000.00
CLPR cash_flow (annual, 2023-12-31) — Net Business Purchase And Sale: 0.00
CLPR balance_sheet (annual, 2023-12-31) — Net Debt: 1183461000.00
CLPR income_statement (annual, 2023-12-31) — Net Income: -5900000.00
CLPR income_statement (annual, 2023-12-31) — Net Income Common Stockholders: -7189000.00
CLPR income_statement (annual, 2023-12-31) — Net Income Continuous Operations: -15565000.00
CLPR income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: -5900000.00
CLPR income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: -5900000.00
CLPR cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: -15565000.00
CLPR income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: -15565000.00
CLPR income_statement (annual, 2023-12-31) — Net Interest Income: -44867000.00
CLPR cash_flow (annual, 2023-12-31) — Net Investment Properties Purchase And Sale: -41357000.00
CLPR cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: 47791000.00
CLPR cash_flow (annual, 2023-12-31) — Net Long Term Debt Issuance: 47791000.00
CLPR income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: -44867000.00
CLPR cash_flow (annual, 2023-12-31) — Net Other Financing Charges: -9666000.00
CLPR balance_sheet (annual, 2023-12-31) — Net Tangible Assets: -3035000.00
CLPR balance_sheet (annual, 2023-12-31) — Non Current Deferred Assets: 2707000.00
CLPR income_statement (annual, 2023-12-31) — Normalized EBITDA: 62466000.00
CLPR income_statement (annual, 2023-12-31) — Normalized Income: -1675000.00
CLPR cash_flow (annual, 2023-12-31) — Operating Cash Flow: 26185000.00
CLPR cash_flow (annual, 2023-12-31) — Operating Gains Losses: 3868000.00
CLPR income_statement (annual, 2023-12-31) — Operating Income: 33527000.00
CLPR income_statement (annual, 2023-12-31) — Operating Revenue: 138205000.00
CLPR balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 16063228.00
CLPR balance_sheet (annual, 2023-12-31) — Other Current Assets: 10854000.00
CLPR income_statement (annual, 2023-12-31) — Other Gand A: 13169000.00
CLPR income_statement (annual, 2023-12-31) — Other Income Expense: -4225000.00
CLPR balance_sheet (annual, 2023-12-31) — Other Intangible Assets: 5779000.00
CLPR cash_flow (annual, 2023-12-31) — Other Non Cash Items: 2514000.00
CLPR balance_sheet (annual, 2023-12-31) — Other Non Current Liabilities: 15477000.00
CLPR income_statement (annual, 2023-12-31) — Other Special Charges: 3868000.00
CLPR income_statement (annual, 2023-12-31) — Otherunder Preferred Stock Dividend: 1289000.00
CLPR balance_sheet (annual, 2023-12-31) — Payables And Accrued Expenses: 20994000.00
CLPR balance_sheet (annual, 2023-12-31) — Preferred Stock: 0.00
CLPR income_statement (annual, 2023-12-31) — Pretax Income: -15565000.00
CLPR cash_flow (annual, 2023-12-31) — Purchase Of Investment Properties: -41357000.00
CLPR balance_sheet (annual, 2023-12-31) — Receivables: 5181000.00
CLPR income_statement (annual, 2023-12-31) — Reconciled Cost Of Revenue: 62702000.00
CLPR income_statement (annual, 2023-12-31) — Reconciled Depreciation: 28807000.00
CLPR income_statement (annual, 2023-12-31) — Rent Expense Supplemental: 62570000.00
CLPR cash_flow (annual, 2023-12-31) — Repayment Of Debt: -84728000.00
CLPR balance_sheet (annual, 2023-12-31) — Restricted Cash: 14062000.00
CLPR income_statement (annual, 2023-12-31) — Restructuring And Mergern Acquisition: 357000.00
CLPR balance_sheet (annual, 2023-12-31) — Retained Earnings: -86899000.00
CLPR cash_flow (annual, 2023-12-31) — Sale Of Business: 0.00
CLPR income_statement (annual, 2023-12-31) — Selling General And Administration: 13169000.00
CLPR balance_sheet (annual, 2023-12-31) — Share Issued: 16063228.00
CLPR income_statement (annual, 2023-12-31) — Special Income Charges: -4225000.00
CLPR cash_flow (annual, 2023-12-31) — Stock Based Compensation: 3015000.00
CLPR balance_sheet (annual, 2023-12-31) — Stockholders Equity: 2744000.00
CLPR balance_sheet (annual, 2023-12-31) — Tangible Book Value: -3035000.00
CLPR income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: 0.00
CLPR income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.00
CLPR balance_sheet (annual, 2023-12-31) — Total Assets: 1249330000.00
CLPR balance_sheet (annual, 2023-12-31) — Total Capitalization: 1208368000.00
CLPR balance_sheet (annual, 2023-12-31) — Total Debt: 1205624000.00
CLPR balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 7235000.00
CLPR income_statement (annual, 2023-12-31) — Total Expenses: 104678000.00
CLPR balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 1242095000.00
CLPR balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 1197070000.00
CLPR balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 1221101000.00
CLPR income_statement (annual, 2023-12-31) — Total Operating Income As Reported: 33170000.00
CLPR income_statement (annual, 2023-12-31) — Total Unusual Items: -4225000.00
CLPR income_statement (annual, 2023-12-31) — Total Unusual Items Excluding Goodwill: -4225000.00
CLPR balance_sheet (annual, 2023-12-31) — Treasury Shares Number: 0.00
CLPR balance_sheet (annual, 2023-12-31) — Working Capital: 31266000.00
CLPR cash_flow (quarterly, 2024-09-30) — Amortization Cash Flow: 0.00
CLPR cash_flow (quarterly, 2024-09-30) — Amortization Of Intangibles: 0.00
CLPR cash_flow (quarterly, 2024-09-30) — Gain Loss On Sale Of PPE: 0.00
CLPR income_statement (quarterly, 2024-09-30) — Gain On Sale Of Ppe: 0.00
CLPR cash_flow (quarterly, 2024-09-30) — Net Investment Purchase And Sale: 0.00
CLPR income_statement (quarterly, 2024-09-30) — Restructuring And Mergern Acquisition: 0.00
CLPR cash_flow (quarterly, 2024-09-30) — Sale Of Investment Properties: 0.00
CLPR income_statement (annual, 2024-12-31) — +Operating Expense: 44044000.00
CLPR income_statement (annual, 2024-12-31) — +Total Revenue: 148775000.00
CLPR balance_sheet (annual, 2024-12-31) — Accounts Receivable: 6365000.00
CLPR balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 89938000.00
CLPR balance_sheet (annual, 2024-12-31) — Allowance For Doubtful Accounts Receivable: -258000.00
CLPR cash_flow (annual, 2024-12-31) — Amortization Cash Flow: 0.00
CLPR cash_flow (quarterly, 2024-12-31) — Amortization Cash Flow: 0.00
CLPR cash_flow (annual, 2024-12-31) — Amortization Of Intangibles: 0.00
CLPR cash_flow (quarterly, 2024-12-31) — Amortization Of Intangibles: 0.00
CLPR cash_flow (annual, 2024-12-31) — Asset Impairment Charge: 30000.00
CLPR income_statement (annual, 2024-12-31) — Basic Average Shares: 16120000.00
CLPR income_statement (annual, 2024-12-31) — Basic EPS: -0.25
CLPR cash_flow (annual, 2024-12-31) — Beginning Cash Position: 36225000.00
CLPR balance_sheet (annual, 2024-12-31) — Capital Stock: 160000.00
CLPR balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 19896000.00
CLPR balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 19896000.00
CLPR cash_flow (annual, 2024-12-31) — Cash Dividends Paid: -17584000.00
CLPR cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: 38746000.00
CLPR cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: -68781000.00
CLPR cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Operating Activities: 31862000.00
CLPR cash_flow (annual, 2024-12-31) — Change In Other Current Liabilities: 345000.00
CLPR cash_flow (annual, 2024-12-31) — Change In Payables And Accrued Expense: -948000.00
CLPR cash_flow (annual, 2024-12-31) — Change In Prepaid Assets: 4785000.00
CLPR cash_flow (annual, 2024-12-31) — Change In Receivables: -1215000.00
CLPR cash_flow (annual, 2024-12-31) — Change In Working Capital: 2967000.00
CLPR cash_flow (annual, 2024-12-31) — Changes In Cash: 1827000.00
CLPR balance_sheet (annual, 2024-12-31) — Common Stock: 160000.00
CLPR cash_flow (annual, 2024-12-31) — Common Stock Dividend Paid: -17584000.00
CLPR balance_sheet (annual, 2024-12-31) — Common Stock Equity: -5409000.00
CLPR income_statement (annual, 2024-12-31) — Cost Of Revenue: 63933000.00
CLPR balance_sheet (annual, 2024-12-31) — Current Assets: 50653000.00
CLPR balance_sheet (annual, 2024-12-31) — Current Liabilities: 18731000.00
CLPR cash_flow (annual, 2024-12-31) — Depreciation: 29786000.00
CLPR cash_flow (annual, 2024-12-31) — Depreciation Amortization Depletion: 29786000.00
CLPR income_statement (annual, 2024-12-31) — Depreciation Amortization Depletion Income Statement: 29892000.00
CLPR cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 29786000.00
CLPR income_statement (annual, 2024-12-31) — Depreciation And Amortization In Income Statement: 29892000.00
CLPR income_statement (annual, 2024-12-31) — Diluted Average Shares: 42437000.00
CLPR income_statement (annual, 2024-12-31) — Diluted EPS: -0.25
CLPR income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: -3976000.00
CLPR income_statement (annual, 2024-12-31) — EBIT: 40529000.00
CLPR income_statement (annual, 2024-12-31) — EBITDA: 70421000.00
CLPR cash_flow (annual, 2024-12-31) — End Cash Position: 38052000.00
CLPR cash_flow (annual, 2024-12-31) — Financing Cash Flow: 38746000.00
CLPR cash_flow (annual, 2024-12-31) — Free Cash Flow: 31862000.00
CLPR cash_flow (annual, 2024-12-31) — Gain Loss On Sale Of PPE: 0.00
CLPR income_statement (annual, 2024-12-31) — Gain On Sale Of Ppe: 0.00
CLPR income_statement (annual, 2024-12-31) — General And Administrative Expense: 14152000.00
CLPR balance_sheet (annual, 2024-12-31) — Goodwill And Other Intangible Assets: 5328000.00
CLPR balance_sheet (annual, 2024-12-31) — Gross Accounts Receivable: 6623000.00
CLPR income_statement (annual, 2024-12-31) — Gross Profit: 84842000.00
CLPR income_statement (annual, 2024-12-31) — Impairment Of Capital Assets: 0.00
CLPR income_statement (annual, 2024-12-31) — Interest Expense: 47111000.00
CLPR income_statement (annual, 2024-12-31) — Interest Expense Non Operating: 47111000.00
CLPR cash_flow (annual, 2024-12-31) — Interest Paid Supplemental Data: 43995000.00
CLPR cash_flow (quarterly, 2024-12-31) — Interest Paid Supplemental Data: 11323000.00
CLPR balance_sheet (annual, 2024-12-31) — Invested Capital: 1260931000.00
CLPR cash_flow (annual, 2024-12-31) — Investing Cash Flow: -68781000.00
CLPR balance_sheet (annual, 2024-12-31) — Investment Properties: 1228528000.00
CLPR cash_flow (annual, 2024-12-31) — Issuance Of Debt: 58330000.00
CLPR balance_sheet (annual, 2024-12-31) — Long Term Debt: 1266340000.00
CLPR balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 1266340000.00
CLPR cash_flow (annual, 2024-12-31) — Long Term Debt Issuance: 58330000.00
CLPR cash_flow (annual, 2024-12-31) — Long Term Debt Payments: -2000000.00
CLPR balance_sheet (annual, 2024-12-31) — Minority Interest: -8821000.00
CLPR income_statement (annual, 2024-12-31) — Minority Interests: 4082000.00
CLPR balance_sheet (annual, 2024-12-31) — Net Debt: 1246444000.00
CLPR income_statement (annual, 2024-12-31) — Net Income: -2500000.00
CLPR income_statement (annual, 2024-12-31) — Net Income Common Stockholders: -3976000.00
CLPR income_statement (annual, 2024-12-31) — Net Income Continuous Operations: -6582000.00
CLPR income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: -2500000.00
CLPR income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: -2500000.00
CLPR cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: -6582000.00
CLPR income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: -6582000.00
CLPR income_statement (annual, 2024-12-31) — Net Interest Income: -47111000.00
CLPR cash_flow (annual, 2024-12-31) — Net Investment Properties Purchase And Sale: -68781000.00
CLPR cash_flow (annual, 2024-12-31) — Net Investment Purchase And Sale: 0.00
CLPR cash_flow (annual, 2024-12-31) — Net Issuance Payments Of Debt: 56330000.00
CLPR cash_flow (annual, 2024-12-31) — Net Long Term Debt Issuance: 56330000.00
CLPR income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: -47111000.00
CLPR balance_sheet (annual, 2024-12-31) — Net Tangible Assets: -10737000.00
CLPR balance_sheet (annual, 2024-12-31) — Non Current Deferred Assets: 2456000.00
CLPR income_statement (annual, 2024-12-31) — Normalized EBITDA: 70690000.00
CLPR income_statement (annual, 2024-12-31) — Normalized Income: -2231000.00
CLPR cash_flow (annual, 2024-12-31) — Operating Cash Flow: 31862000.00
CLPR income_statement (annual, 2024-12-31) — Operating Income: 40798000.00
CLPR income_statement (annual, 2024-12-31) — Operating Revenue: 148775000.00
CLPR balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 16146546.00
CLPR balance_sheet (annual, 2024-12-31) — Other Current Assets: 6236000.00
CLPR income_statement (annual, 2024-12-31) — Other Gand A: 14152000.00
CLPR income_statement (annual, 2024-12-31) — Other Income Expense: -269000.00
CLPR balance_sheet (annual, 2024-12-31) — Other Intangible Assets: 5328000.00
CLPR cash_flow (annual, 2024-12-31) — Other Non Cash Items: 2960000.00
CLPR balance_sheet (annual, 2024-12-31) — Other Non Current Liabilities: 16124000.00
CLPR income_statement (annual, 2024-12-31) — Other Special Charges: 269000.00
CLPR income_statement (annual, 2024-12-31) — Otherunder Preferred Stock Dividend: 1476000.00
CLPR balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 18731000.00
CLPR balance_sheet (annual, 2024-12-31) — Preferred Stock: 0.00
CLPR income_statement (annual, 2024-12-31) — Pretax Income: -6582000.00
CLPR cash_flow (annual, 2024-12-31) — Purchase Of Investment Properties: -68781000.00
CLPR balance_sheet (annual, 2024-12-31) — Receivables: 6365000.00
CLPR income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 64039000.00
CLPR income_statement (annual, 2024-12-31) — Reconciled Depreciation: 29786000.00
CLPR income_statement (annual, 2024-12-31) — Rent Expense Supplemental: 63933000.00
CLPR cash_flow (annual, 2024-12-31) — Repayment Of Debt: -2000000.00
CLPR balance_sheet (annual, 2024-12-31) — Restricted Cash: 18156000.00
CLPR income_statement (annual, 2024-12-31) — Restructuring And Mergern Acquisition: 0.00
CLPR income_statement (quarterly, 2024-12-31) — Restructuring And Mergern Acquisition: 0.00
CLPR balance_sheet (annual, 2024-12-31) — Retained Earnings: -95507000.00
CLPR cash_flow (annual, 2024-12-31) — Sale Of Investment Properties: 0.00
CLPR income_statement (annual, 2024-12-31) — Selling General And Administration: 14152000.00
CLPR balance_sheet (annual, 2024-12-31) — Share Issued: 16146546.00
CLPR income_statement (annual, 2024-12-31) — Special Income Charges: -269000.00
CLPR cash_flow (annual, 2024-12-31) — Stock Based Compensation: 2701000.00
CLPR balance_sheet (annual, 2024-12-31) — Stockholders Equity: -5409000.00
CLPR balance_sheet (annual, 2024-12-31) — Tangible Book Value: -10737000.00
CLPR income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
CLPR income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.00
CLPR balance_sheet (annual, 2024-12-31) — Total Assets: 1286965000.00
CLPR balance_sheet (annual, 2024-12-31) — Total Capitalization: 1260931000.00
CLPR balance_sheet (annual, 2024-12-31) — Total Debt: 1266340000.00
CLPR balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: -14230000.00
CLPR income_statement (annual, 2024-12-31) — Total Expenses: 107977000.00
CLPR balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 1301195000.00
CLPR balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 1236312000.00
CLPR balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 1282464000.00
CLPR income_statement (annual, 2024-12-31) — Total Operating Income As Reported: 40529000.00
CLPR income_statement (annual, 2024-12-31) — Total Unusual Items: -269000.00
CLPR income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: -269000.00
CLPR balance_sheet (annual, 2024-12-31) — Working Capital: 31922000.00
CLPR income_statement (quarterly, 2025-03-31) — +Operating Expense: 11461000.00
CLPR income_statement (quarterly, 2025-03-31) — +Total Revenue: 39398000.00
CLPR balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 6974000.00
CLPR balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 90152000.00
CLPR balance_sheet (quarterly, 2025-03-31) — Allowance For Doubtful Accounts Receivable: -246000.00
CLPR cash_flow (quarterly, 2025-03-31) — Asset Impairment Charge: 33767000.00
CLPR balance_sheet (quarterly, 2025-03-31) — Assets Held For Sale Current: 45903000.00
CLPR income_statement (quarterly, 2025-03-31) — Basic Average Shares: 16147000.00
CLPR income_statement (quarterly, 2025-03-31) — Basic EPS: -0.86
CLPR cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 38052000.00
CLPR balance_sheet (quarterly, 2025-03-31) — Capital Stock: 160000.00
CLPR balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 21288000.00
CLPR balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 21288000.00
CLPR cash_flow (quarterly, 2025-03-31) — Cash Dividends Paid: 0.00
CLPR cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: 5543000.00
CLPR cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: -9680000.00
CLPR cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: 6676000.00
CLPR cash_flow (quarterly, 2025-03-31) — Change In Other Current Liabilities: 1114000.00
CLPR cash_flow (quarterly, 2025-03-31) — Change In Other Working Capital: 64000.00
CLPR cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: 297000.00
CLPR cash_flow (quarterly, 2025-03-31) — Change In Prepaid Assets: -2149000.00
CLPR cash_flow (quarterly, 2025-03-31) — Change In Receivables: -693000.00
CLPR cash_flow (quarterly, 2025-03-31) — Change In Working Capital: -1367000.00
CLPR cash_flow (quarterly, 2025-03-31) — Changes In Cash: 2539000.00
CLPR balance_sheet (quarterly, 2025-03-31) — Common Stock: 160000.00
CLPR cash_flow (quarterly, 2025-03-31) — Common Stock Dividend Paid: 0.00
CLPR balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: -20076000.00
CLPR income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 17738000.00
CLPR balance_sheet (quarterly, 2025-03-31) — Current Assets: 100154000.00
CLPR balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 19649000.00
CLPR cash_flow (quarterly, 2025-03-31) — Depreciation: 7611000.00
CLPR cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 7611000.00
CLPR income_statement (quarterly, 2025-03-31) — Depreciation Amortization Depletion Income Statement: 7636000.00
CLPR cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 7611000.00
CLPR income_statement (quarterly, 2025-03-31) — Depreciation And Amortization In Income Statement: 7636000.00
CLPR income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 16147000.00
CLPR income_statement (quarterly, 2025-03-31) — Diluted EPS: -0.86
CLPR income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: -13927000.00
CLPR income_statement (quarterly, 2025-03-31) — EBIT: -23581000.00
CLPR income_statement (quarterly, 2025-03-31) — EBITDA: -15945000.00
CLPR cash_flow (quarterly, 2025-03-31) — End Cash Position: 39111000.00
CLPR cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: 5543000.00
CLPR cash_flow (quarterly, 2025-03-31) — Free Cash Flow: 6676000.00
CLPR income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 3825000.00
CLPR balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 5212000.00
CLPR balance_sheet (quarterly, 2025-03-31) — Gross Accounts Receivable: 7220000.00
CLPR income_statement (quarterly, 2025-03-31) — Gross Profit: 21660000.00
CLPR income_statement (quarterly, 2025-03-31) — Impairment Of Capital Assets: 33780000.00
CLPR income_statement (quarterly, 2025-03-31) — Interest Expense: 11522000.00
CLPR income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 11522000.00
CLPR cash_flow (quarterly, 2025-03-31) — Interest Paid Supplemental Data: 11188000.00
CLPR balance_sheet (quarterly, 2025-03-31) — Invested Capital: 1252830000.00
CLPR cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: -9680000.00
CLPR balance_sheet (quarterly, 2025-03-31) — Investment Properties: 1154283000.00
CLPR cash_flow (quarterly, 2025-03-31) — Issuance Of Debt: 6371000.00
CLPR balance_sheet (quarterly, 2025-03-31) — Liabilities Heldfor Sale Non Current: 886000.00
CLPR balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 1272906000.00
CLPR balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 1272906000.00
CLPR cash_flow (quarterly, 2025-03-31) — Long Term Debt Issuance: 6371000.00
CLPR cash_flow (quarterly, 2025-03-31) — Long Term Debt Payments: -578000.00
CLPR balance_sheet (quarterly, 2025-03-31) — Minority Interest: -32728000.00
CLPR income_statement (quarterly, 2025-03-31) — Minority Interests: 21756000.00
CLPR balance_sheet (quarterly, 2025-03-31) — Net Debt: 1251618000.00
CLPR income_statement (quarterly, 2025-03-31) — Net Income: -13347000.00
CLPR income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: -13927000.00
CLPR income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: -35103000.00